CSFZX | FIREX | CSFZX / FIREX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 10 years | 20 years | - |
Gain YTD | 3.036 | 3.941 | 77% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.79B | 294M | 610% |
Annual Yield % from dividends | 2.91 | 1.92 | 152% |
Returns for 1 year | 7.75 | 0.36 | 2,142% |
Returns for 3 years | -5.89 | -24.78 | 24% |
Returns for 5 years | 1.87 | -21.42 | -9% |
Returns for 10 years | 35.75 | -1.96 | -1,822% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RYWUX | 66.05 | 1.33 | +2.06% |
Rydex Emerging Markets 2X Strategy C | |||
NQGAX | 36.33 | -0.37 | -1.01% |
Nuveen Global Equity Income A | |||
ETIHX | 35.38 | -0.37 | -1.03% |
Eventide Healthcare & Life Sciences I | |||
GSLAX | 16.33 | -0.24 | -1.45% |
Goldman Sachs Large Cap Value A | |||
OLVRX | 20.83 | -0.44 | -2.07% |
JPMorgan Large Cap Value R4 |